8-KLeadership ChangesExhibits & Filings

BECTON DICKINSON & CO 8-K Report, Executive Changes (Aug 30, 2024)

Filed August 30, 2024For Securities:BDX

Summary

Becton Dickinson & Co. (BDX) has announced a key executive leadership change, effective August 30th, 2024. Thomas Spoerel will transition from his role as Principal Accounting Officer to Senior Vice President, CFO Regions. In this new capacity, Spoerel will lead the financial integration of the recently announced acquisition of Edwards Lifesciences' Critical Care product group. This move signals a strategic focus on integrating the new business and leveraging regional finance leadership. Following Spoerel's departure from the Principal Accounting Officer role, Christopher DelOrefice, Executive Vice President and Chief Financial Officer, will assume these responsibilities on an interim basis. This appointment is designed to ensure continuity in financial reporting and oversight during this transition period. Investors should monitor the progress of the Edwards Life Sciences acquisition integration and its impact on BDX's financial performance.

Key Highlights

  • 1Thomas Spoerel appointed Senior Vice President, CFO Regions, effective August 30, 2024.
  • 2Spoerel will lead financial integration for the acquisition of Edwards Lifesciences' Critical Care product group.
  • 3Thomas Spoerel is no longer the Company's Principal Accounting Officer.
  • 4Christopher DelOrefice, EVP and CFO, will serve as interim Principal Accounting Officer.
  • 5The filing reports a leadership transition related to financial operations and a major acquisition.

Frequently Asked Questions

Thomas Spoerel's role change is to focus on leading the financial integration of Becton Dickinson's recently announced acquisition of Edwards Lifesciences' Critical Care product group.

Christopher DelOrefice, Executive Vice President and Chief Financial Officer, will assume the responsibilities of Principal Accounting Officer on an interim basis.

Christopher DelOrefice's interim appointment as Principal Accounting Officer is intended to ensure continuity in financial reporting and oversight during this transition period.

The acquisition of Edwards Lifesciences' Critical Care product group is a significant strategic move for BDX, and Thomas Spoerel's new role indicates a focused effort on its financial integration, which will be key to realizing the value of this transaction.